Risk factors for breast cancer development by tumor characteristics among women with benign breast disease

Among women diagnosed with invasive breast cancer, 30% have a prior diagnosis of benign breast disease (BBD). Thus, it is important to identify factors among BBD patients that elevate invasive cancer risk. In the general population, risk factors differ in their associations by clinical pathologic fe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Breast cancer research : BCR 2021-03, Vol.23 (1), p.34-34, Article 34
Hauptverfasser: Figueroa, Jonine D, Gierach, Gretchen L, Duggan, Máire A, Fan, Shaoqi, Pfeiffer, Ruth M, Wang, Yihong, Falk, Roni T, Loudig, Olivier, Abubakar, Mustapha, Ginsberg, Mindy, Kimes, Teresa M, Richert-Boe, Kathryn, Glass, Andrew G, Rohan, Thomas E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Among women diagnosed with invasive breast cancer, 30% have a prior diagnosis of benign breast disease (BBD). Thus, it is important to identify factors among BBD patients that elevate invasive cancer risk. In the general population, risk factors differ in their associations by clinical pathologic features; however, whether women with BBD show etiologic heterogeneity in the types of breast cancers they develop remains unknown. Using a nested case-control study of BBD and breast cancer risk conducted in a community healthcare plan (Kaiser Permanente Northwest), we assessed relationships of histologic features in BBD biopsies and patient characteristics with subsequent breast cancer risk and tested for heterogeneity of associations by estrogen receptor (ER) status, tumor grade, and size. The study included 514 invasive breast cancer cases (median follow-up of 9 years post-BBD diagnosis) and 514 matched controls, diagnosed with proliferative or non-proliferative BBD between 1971 and 2006, with follow-up through mid-2015. Odds ratios (ORs) and 95% confidence intervals (CIs) were obtained using multivariable polytomous logistic regression models. Breast cancers were predominantly ER-positive (86%), well or moderately differentiated (73%), small (74%
ISSN:1465-542X
1465-5411
1465-542X
DOI:10.1186/s13058-021-01410-1